KELLY JOHN ALEXANDER (Interim CFO) sold 6.1% of their position (8.15K shares) of PRECISION BIOSCIENCES INC on the open market
Open‑market sale worth $31.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/19/2026ACC: 0001628280-26-009803
Officer· Interim CFO
Since Jan 2021
-8.15K
Net shares
Net seller
$31.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
27.58K acquired · 35.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+27.58K
Price / share
—
Trade value
—
% of position
25.9%
2/17/2026
106.45K→134.03K
Common Stock
Direct
Shares
−8.15K
Price / share
$3.84
Trade value
$31.29K
% of position
6.1%
2/18/2026
134.03K→125.88K
Total
Net shares
+19.43K
Net value
-$31.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +27.58K | — | — | 25.9% | 106.45K | 134.03K |
| Common Stock Direct | 2/18/2026 | S · Sale | −8.15K | $3.84 | $31.29K | 6.1% | 134.03K | 125.88K |
| Total | +19.43K | -$31.29K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
27.58K shares
Shares
−27.58K
Strike price
Held after
55.17K
Exercisable
—
2/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock27.58K shares | 2/17/2026 | M · Option Exercise | −27.58K | — | 55.17K |